For a medication you will likely take for months or years, understanding the worst-case scenarios is just as important as understanding the best-case ones
Physiology-Cell Physiology 322 (4), C61423
GLP-1 medications typically show initial effects on blood glucose within 1 to 2 weeks and appetite suppression within days to weeks, but reaching full therapeutic response takes longer as doses gradually increase
To view a copy of this licence, visit About this article Cite this article Liu, Y., Hu, Y., Ma, B
Dubin, D
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound)